Video
ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy
April 3, 2022
C. Michael Gibson and Milind Desai discuss the VALOR-HCM results presented at ACC 2022.